Renaissance Technologies LLC decreased its position in shares of PDL BioPharma Inc by 4.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission . The fund owned 12,875,700 shares of the company’s stock after selling 597,154 shares during the period.